Lv4
440 积分 2024-05-08 加入
Lymphocyte profile in peripheral blood of patients with multiple myeloma
1天前
已完结
Immune profiles to predict bortezomib-based treatment response for multiple myeloma patients
2天前
已完结
Safety and efficacy of apixaban for routine thromboprophylaxis in myeloma patients treated with thalidomide‐ and lenalidomide‐containing regimens
6天前
已完结
Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents
6天前
已完结
Safety and efficacy of apixaban as thromboprophylaxis in myeloma patients receiving chemotherapy: A prospective cohort study
6天前
已完结
Monoclonal gammopathy of undetermined significance and the risk of thrombotic events: Results from iStopMM, a prospective population‐based screening study
19天前
已完结
Advances and current research in primary thromboprophylaxis to prevent hospital‐associated venous thromboembolism
19天前
已完结
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival
19天前
已完结
The comparative efficacy and safety of factor Xa inhibitors and warfarin for primary thromboprophylaxis in multiple myeloma patients undergoing immunomodulatory therapy
19天前
已完结
Thrombosis events in Chinese patients with newly diagnosed multiple myeloma
20天前
已完结
皖公网安备34019202002308
